Dr. Marwan Mounayar, MD

Dr. Mounayar practices at IU Health Ball Memorial Hospital in Muncie, Indiana, part of Indiana University Health.

Dr. Mounayar's NPI, 1689012676, was assigned on June 12, 2013. Dr. Mounayar holds Indiana license 01082323A.

Dr. Mounayar's primary practice is IU Health Ball Memorial Hospital, at 2401 University Ave, Muncie, IN 47303 in Delaware County. The practice phone is (765) 747-3111.

Dr. Mounayar's primary practice is IU Health Ball Memorial Hospital in Muncie, Indiana, part of Indiana University Health. Dr. Mounayar is also affiliated with IU Health Methodist Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Mounayar to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mounayar practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mounayar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mounayar is licensed in Indiana.

CMS data shows 1,053 Medicare services from Dr. Mounayar across 8 procedure codes in 2024, for 297 Medicare patients. Medicare paid $88,096 for them.

CMS counts 297 Medicare patients who saw Dr. Mounayar in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mounayar's median patient age at 69, with 59% women.

In 2024, Dr. Mounayar wrote 1,516 Medicare Part D claims for 281 patients. 78% of them were for generic drugs. CMS names the drug for 1,189 of them, across 39 drugs with 11 or more claims each, at $2,472,040 in total drug cost. In 2023, CMS named 1,051 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Mounayar for performance year 2024, reported individually. Dr. Mounayar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Mounayar, published from 2011 to 2024. 2014 was the busiest year, with 3. The most frequent topics are Diabetes Mellitus, Type 1, Insulin-Secreting Cells and Mesenchymal Stem Cells. Dr. Mounayar's most frequent co-authors are Jamil R. Azzi, MD, Ibrahim Batal, MD and Ciara Noelle Magee, BAO, BCH, MB.

Dmand AI links Dr. Mounayar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 6 general payments to Dr. Mounayar from 6 drug and device companies from 2017 to 2025. Education make up the largest share, 72% of the total. Alexion Pharmaceuticals, Inc. paid the most, $90.